logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Disruptive Psychopharmacology Frederick S Barrett Katrin H Preller

  • SKU: BELL-44985736
Disruptive Psychopharmacology Frederick S Barrett Katrin H Preller
$ 31.00 $ 45.00 (-31%)

5.0

78 reviews

Disruptive Psychopharmacology Frederick S Barrett Katrin H Preller instant download after payment.

Publisher: Springer
File Extension: PDF
File size: 5.56 MB
Pages: 329
Author: Frederick S. Barrett, Katrin H. Preller, (eds.)
ISBN: 9783031121838, 303112183X
Language: English
Year: 2022

Product desciption

Disruptive Psychopharmacology Frederick S Barrett Katrin H Preller by Frederick S. Barrett, Katrin H. Preller, (eds.) 9783031121838, 303112183X instant download after payment.

Psychedelic therapies are gaining traction as potential treatments for a wide range of indications, but the structure and delivery of psychedelic therapies are a sharp departure from more traditional models of psychotherapy and pharmacotherapy for psychiatric and other medical disorders. This may be critical to their success. The current volume provides a comprehensive review of the state of the science of psychedelic therapies, including discussion of models and approaches to psychedelic therapies as well as the current status of safety and efficacy data for mood, substance use, trauma, obsessive-compulsive, neurodevelopmental, neurodegenerative disorders, neurological, and inflammatory disorders.

Related Products